Treatments aimed at restoring IGF-1 brain levels in MCAO rodent models reduced the infarct volume [142] and the rate of apoptosis [143], improving cognitive deficits through the IGF-1/AKT pathway [144]. The gene discussed is IGF1; the disease is Cognitive impairment.